Physician profile
David C Raab
NPI 1245216902
$4,723.77
in general payments reported to CMS, 2019-2025
12 companies · $72.85 in 2025
The $72.85 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,855 · 2020: $46.68 · 2021: $2,575 · 2022: $61.78 · 2023: $42.95 · 2024: $69.69 · 2025: $72.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,250.00 | 2021 | |
| Synthes USA Products LLC | $1,580.00 | 2019 | |
| Smith+Nephew, INC. | $365.97 | 2019-2022 | |
| Stryker Corporation | $217.77 | 2019-2023 | Inspace |
| Anika Therapeutics, INC. | $82.78 | 2024-2025 | Integrity Implant, Tactoset, X-Twist |
| Abbott Laboratories | $59.76 | 2024-2025 | Octrode |
| Depuy Synthes Sales INC. | $41.08 | 2019-2020 | |
| Radius Health, INC. | $39.72 | 2022 | |
| Horizon Therapeutics Plc | $30.13 | 2019 | |
| Orthogenrx INC. | $20.26 | 2020 | |
| Abbvie INC. | $19.63 | 2023 | |
| Pacira Therapeutics, INC. | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Raab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.